RESPeRATE, a new hypertension device is introduced to retailers and consumers

Dascal recently undertook to help InterCure Inc. reposition the branding and consumer messaging for RESPeRATE – the first and only FDA-cleared, nondrug, noninvasive hypertension treatment device – to launch the product throughout retail pharmacy chains in the United States. Our multifaceted campaign comprised branding guidelines, product packaging, retail merchandising, consumer demo units as well as sales presentation tools. These elements were shared globally with all stakeholders in order to ensure promotional consistency while generating sales and building brand equity. Because InterCure is a public company, part of the process included building consensus among shareholders and key stakeholders to help ensure support for the successful retail launch of RESPeRATE. The project encompassed retail and consumer positioning, branding, and messaging review process, as well as the establishment of the visual brand foundation.